Selected research
Market Structure
Global Autacoids and Related Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Autacoids and Related Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Autacoids and Related Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Autacoids and Related Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Autacoids and Related Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Autacoids and Related Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Autacoids and Related Drugs include Sanofi, AstraZeneca, Fresenius, Bristol-Myers Squibb, Bedford Laboratories and Abbott Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Autacoids and Related Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Autacoids and Related Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Autacoids and Related Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Autacoids and Related Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.
Autacoids and Related Drugs Segment by Company
Sanofi
AstraZeneca
Fresenius
Bristol-Myers Squibb
Bedford Laboratories
Abbott Laboratories
Autacoids and Related Drugs Segment by Type
Polypeptides
Eicosanoids
Decarboxylated Amino Acids
Autacoids and Related Drugs Segment by Application
Allergies
Chronic Pain
Neuroendocrine Regulation
Gastrointestinal Diseases
Gastric Acid Secretion
Cardiovascular Diseases
Inflammation
Autacoids and Related Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autacoids and Related Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Autacoids and Related Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autacoids and Related Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Autacoids and Related Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autacoids and Related Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Autacoids and Related Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Autacoids and Related Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Polypeptides
- Eicosanoids
- Decarboxylated Amino Acids
Applications
- Allergies
- Chronic Pain
- Neuroendocrine Regulation
- Gastrointestinal Diseases
- Gastric Acid Secretion
- Cardiovascular Diseases
- Inflammation
Companies covered
- Sanofi
- AstraZeneca
- Fresenius
- Bristol-Myers Squibb
- Bedford Laboratories
- Abbott Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Autacoids and Related Drugs Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Autacoids and Related Drugs Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Autacoids and Related Drugs Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Autacoids and Related Drugs Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Autacoids and Related Drugs Market Dynamics
- 2.1 Autacoids and Related Drugs Industry Trends
- 2.2 Autacoids and Related Drugs Industry Drivers
- 2.3 Autacoids and Related Drugs Industry Opportunities and Challenges
- 2.4 Autacoids and Related Drugs Industry Restraints
3 Autacoids and Related Drugs Market by Manufacturers
- 3.1 Global Autacoids and Related Drugs Revenue by Manufacturers (2021-2026)
- 3.2 Global Autacoids and Related Drugs Sales by Manufacturers (2021-2026)
- 3.3 Global Autacoids and Related Drugs Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Autacoids and Related Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Autacoids and Related Drugs Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Autacoids and Related Drugs Manufacturers, Product Type & Application
- 3.7 Global Autacoids and Related Drugs Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Autacoids and Related Drugs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Autacoids and Related Drugs Players Market Share by Revenue in 2025
- 3.8.3 2025 Autacoids and Related Drugs Tier 1, Tier 2, and Tier 3
4 Autacoids and Related Drugs Market by Type
- 4.1 Autacoids and Related Drugs Type Introduction
- 4.1.1 Polypeptides
- 4.1.2 Eicosanoids
- 4.1.3 Decarboxylated Amino Acids
- 4.2 Global Autacoids and Related Drugs Sales by Type
- 4.2.1 Global Autacoids and Related Drugs Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Autacoids and Related Drugs Sales by Type (2021-2032)
- 4.2.3 Global Autacoids and Related Drugs Sales Market Share by Type (2021-2032)
- 4.3 Global Autacoids and Related Drugs Revenue by Type
- 4.3.1 Global Autacoids and Related Drugs Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Autacoids and Related Drugs Revenue by Type (2021-2032)
- 4.3.3 Global Autacoids and Related Drugs Revenue Market Share by Type (2021-2032)
5 Autacoids and Related Drugs Market by Application
- 5.1 Autacoids and Related Drugs Application Introduction
- 5.1.1 Allergies
- 5.1.2 Chronic Pain
- 5.1.3 Neuroendocrine Regulation
- 5.1.4 Gastrointestinal Diseases
- 5.1.5 Gastric Acid Secretion
- 5.1.6 Cardiovascular Diseases
- 5.1.7 Inflammation
- 5.2 Global Autacoids and Related Drugs Sales by Application
- 5.2.1 Global Autacoids and Related Drugs Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Autacoids and Related Drugs Sales by Application (2021-2032)
- 5.2.3 Global Autacoids and Related Drugs Sales Market Share by Application (2021-2032)
- 5.3 Global Autacoids and Related Drugs Revenue by Application
- 5.3.1 Global Autacoids and Related Drugs Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Autacoids and Related Drugs Revenue by Application (2021-2032)
- 5.3.3 Global Autacoids and Related Drugs Revenue Market Share by Application (2021-2032)
6 Global Autacoids and Related Drugs Sales by Region
- 6.1 Global Autacoids and Related Drugs Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Autacoids and Related Drugs Sales by Region (2021-2032)
- 6.2.1 Global Autacoids and Related Drugs Sales by Region (2021-2026)
- 6.2.2 Global Autacoids and Related Drugs Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Autacoids and Related Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Autacoids and Related Drugs Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Autacoids and Related Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Autacoids and Related Drugs Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Autacoids and Related Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Autacoids and Related Drugs Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Autacoids and Related Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Autacoids and Related Drugs Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Autacoids and Related Drugs Revenue by Region
- 7.1 Global Autacoids and Related Drugs Revenue by Region
- 7.1.1 Global Autacoids and Related Drugs Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Autacoids and Related Drugs Revenue by Region (2021-2026)
- 7.1.3 Global Autacoids and Related Drugs Revenue by Region (2027-2032)
- 7.1.4 Global Autacoids and Related Drugs Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Autacoids and Related Drugs Revenue (2021-2032)
- 7.2.2 North America Autacoids and Related Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Autacoids and Related Drugs Revenue (2021-2032)
- 7.3.2 Europe Autacoids and Related Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Autacoids and Related Drugs Revenue (2021-2032)
- 7.4.2 Asia-Pacific Autacoids and Related Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Autacoids and Related Drugs Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Autacoids and Related Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sanofi
- 8.1.1 Sanofi Company Information
- 8.1.2 Sanofi Business Overview
- 8.1.3 Sanofi Autacoids and Related Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sanofi Autacoids and Related Drugs Product Portfolio
- 8.1.5 Sanofi Recent Developments
- 8.2 AstraZeneca
- 8.2.1 AstraZeneca Company Information
- 8.2.2 AstraZeneca Business Overview
- 8.2.3 AstraZeneca Autacoids and Related Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 AstraZeneca Autacoids and Related Drugs Product Portfolio
- 8.2.5 AstraZeneca Recent Developments
- 8.3 Fresenius
- 8.3.1 Fresenius Company Information
- 8.3.2 Fresenius Business Overview
- 8.3.3 Fresenius Autacoids and Related Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Fresenius Autacoids and Related Drugs Product Portfolio
- 8.3.5 Fresenius Recent Developments
- 8.4 Bristol-Myers Squibb
- 8.4.1 Bristol-Myers Squibb Company Information
- 8.4.2 Bristol-Myers Squibb Business Overview
- 8.4.3 Bristol-Myers Squibb Autacoids and Related Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Bristol-Myers Squibb Autacoids and Related Drugs Product Portfolio
- 8.4.5 Bristol-Myers Squibb Recent Developments
- 8.5 Bedford Laboratories
- 8.5.1 Bedford Laboratories Company Information
- 8.5.2 Bedford Laboratories Business Overview
- 8.5.3 Bedford Laboratories Autacoids and Related Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Bedford Laboratories Autacoids and Related Drugs Product Portfolio
- 8.5.5 Bedford Laboratories Recent Developments
- 8.6 Abbott Laboratories
- 8.6.1 Abbott Laboratories Company Information
- 8.6.2 Abbott Laboratories Business Overview
- 8.6.3 Abbott Laboratories Autacoids and Related Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Abbott Laboratories Autacoids and Related Drugs Product Portfolio
- 8.6.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Autacoids and Related Drugs Value Chain Analysis
- 9.1.1 Autacoids and Related Drugs Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Autacoids and Related Drugs Production Mode & Process
- 9.2 Autacoids and Related Drugs Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Autacoids and Related Drugs Distributors
- 9.2.3 Autacoids and Related Drugs Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst